Skip to main content
. 2019 Jan 1;2019:8742363. doi: 10.1155/2019/8742363

Table 2.

Summary results of MDR–TB by clinical characteristics.

Covariates Category Death (%) Censored (%) Total (%)
Any clinical complication No complication 35(20.35) 137(79.65) 172
Pneumonia 7(87.5) 1(12.5) 8
Pneumothorax 6(85.71) 1(14.29) 7
Hemoptysis 7(63.64) 4(36.36) 11
Cor pulmonal 4(100) 0(0) 4
Other 2(40) 3(60) 5
HIV Co-infection Positive 21(61.76) 13(38.24) 34
Negative 40(23.12) 133(76.88) 173
Acid-fast bacilli Smear (AFB) positive 43(28.28) 109(71.71) 152
Negative 12(30) 28(70) 40
Antibiotic Susceptibility INH 6(72.86) 8(57.14) 14
RMP 24(30.38) 55(69.62) 79
MDR 26(30.95) 58(69.05) 84
INH+RMP 5(16.67) 25(83.33) 30
Presence of any chronic disease No chronic disease 42(24.14) 132(75.86) 174
Diabetes Mellitus 8(50) 8(50) 16
Myocardial infarction 4(100) 0(0) 4
Asthma 4(66.66) 2(33.33) 6
other 1(33.33) 2(66.67) 3
Radiological findings unilateral cavity 9(26.47) 25(73.53) 34
unilateral infiltration 3(33.33) 6(66.67) 9
Bilateral cavity 4(18.18) 18(81.82) 22
Bilateral inflation 7(38.89) 11(61.12) 18
Non cavity 14(27.45) 37(72.55) 51
Effusion 12(37.5) 20(62.5) 32
Smear positivity Positive 46(31.94) 98(68.06) 144
Negative 14(26.42) 39(73.58) 53
Clinical Presentation Pulmonary 51(30) 119(70) 170
Extra pulmonary 8(28.57) 20(71.43) 28

INH: isoniazid; RMP: rifampicin; MDR: multidrug-resistant.